Metastatic Breast Cancer Treatment Options Metastatic breast cancer also called stage IV or advanced breast cancer is not a specific type of cancer, rather it is the most advanced stage of breast cancer. It is the worst stage of cancer that has spread beyond the breast to other organs in the body, most often the bones, lungs, liver or brains It is estimated that at least 154,000 people in the united states have metastatic breast cancer. More commonly, this cancer arises months or years after a person has completed treatment for early or locally advanced stage 1, 2, or 3 breast cancer Now let see what treatment options we got for metastatic breast cancer 1. Hormone therapy 2:15 2. Chemotherapy 2:47 3. Targeted therapy 3:39 Now that you know in detail, about each of the metastatic breast cancer treatment options available in the medical science. However, beware that each method has it's own side effects. Best thing we recommend is to turn towards nature and stay away from modern food culture and hectic lifestyles. ------------------------------------------------------------------------------------------------------------ For more health tips visit ► http://www.healthveins.com Follow us on Facebook ► http://www/facebook.com/healthveins Join Facebook Group ► https://www.facebook.com/groups/225183354567275/ ------------------------------------------------------------------------------------------------------------ Disclaimer: The videos posted by Healthveins are for an educational or informational purpose only, and we are not liable for any harm or side effects if caused. You may use the remedies at your own risk. The Channel / Author does not provide medical advice. Consult with your doctor or other health care provider before using any of these tips or treatments. Copyright We reserve copyright for the music, voice, and animations used in the video. Reusing our video would violate copyright rules, And if found they could face legal copyright claims. Any images used are complying with the youtube terms: https://www.youtube.com/yt/copyright/fair-use.html
Просмотров: 2706 Healthveins
Subscribe to The Doctors: http://bit.ly/SubscribeTheDrs LIKE us on Facebook: http://bit.ly/FacebookTheDoctors Follow us on Twitter: http://bit.ly/TheDrsTwitter Follow us on Pinterest: http://bit.ly/PinterestTheDrs October is Breast Cancer Awareness Month. Pfizer’s Chief Medical Officer Dr. Freda Lewis-Hall explains metastatic breast cancer, a condition that affects nearly 250,000 Americans, most of whom are women. Learn the common misconceptions about the disease, and meet a cancer patient who isn’t letting her diagnosis keep her down.
Просмотров: 18693 The Doctors
Robin Miller was an extraordinary woman, and her story must be shared. Living for 12 years with metastatic breast cancer, through most of her 20s and until she was 34, Robin dedicated her life to helping others. A majority of her work was in Lymphedema. She ultimately revolutionized the Lymphedema industry through her "disruptive" work in co-founding LympheDIVAs, her ongoing work at the National Lymphedema Network, and more. Robin was a fighter and she'd be proud to be known as an all-around "bad ass". Her struggle was gargantuan, yet she powered through it sharp-tongued and unapologetic, fighting for the rights of patients and towards a cure. She is grateful to her family and friends, who she loved so dearly, and to the medical staff whom she turned into partners over time. You can experience Robin here in this video, just months before her hard fight came to an end. May we all carry with us the fearless nature of this woman. And as Robin would say, "Fuck Cancer." Learn more about Robin's story at: https://robinmiller4eva.com Contributions in her memory may be sent to The Hope Rugo Breast Cancer Research Fund at UCSF, https://crowdfund.ucsf.edu/forrobinmiller.
Просмотров: 14813 Anne Tacchino
Stage IV breast cancer is responsible for virtually all breast-cancer deaths, and yet, while we practically drown in pink ribbons and breast-cancer awareness year after year, 61% of Americans say they know little to nothing about metastatic breast cancer, according to a recent survey. All month long this October, Refinery29, in partnership with #Cancerland, has been bringing you these women's stories, in an effort to change the conversation about breast cancer. We've talked about how only about 2% of the money raised for breast cancer research goes toward metastatic disease, and we followed stage-IV activists to D.C. as they lobbied congress to change that. But as October comes to an end, we want to turn to the daily, lived experiences of these women: What is it really like to live with a disease that everyone seems to have heard of, but no one really understands? Read the article: http://www.refinery29.com/2016/10/127455/metastatic-breast-cancer-stage-4-stories#slide Subscribe to the Refinery29 channel: http://bit.ly/subscribe-to-r29 For the latest trends and videos, visit: refinery29 [dot] com Like Refinery29 on Facebook: Refinery29 Follow Refinery29 on Twitter: @refinery29 Heart Refinery29 on Instagram: @refinery29
Просмотров: 44257 Refinery29
Propelled Breast Cancer Patient Guide Getting Support and Finding Resources. There's a huge amount of data and support for individuals with bosom growth. Be that as it may, as a man living with metastatic bosom disease, your requirements might be to some degree not quite the same as the individuals who have prior stage bosom growth. Your best asset for restorative data is your oncology group. They can furnish you with instructive materials particular to cutting edge bosom malignancy. Odds are you'll presumably need data about an assortment of different parts of existence with metastatic bosom disease, as well. A few associations give supportive materials particularly to individuals with cutting edge bosom growth. Here are some great spots to begin: Propelled Breast Cancer Community. American Cancer Society. BreastCancer.org. Metastatic Breast Cancer Network. Passionate and social help: Living with cutting edge bosom growth, you no uncertainty have a considerable measure at the forefront of your thoughts. With all the treatment choices, physical changes, and reactions, it wouldn't be at all strange in the event that you felt overpowered on occasion. Whatever feelings you're feeling, they're not off-base. You don't need to satisfy any other person's assumptions about how you should feel or what you ought to do. In any case, you may need somebody to converse with. You could possibly have a companion, family, or companions who can give passionate and social help. Regardless of whether you do, you could in any case advantage from associating with other people who are additionally living with metastatic disease. This is a gathering of individuals who will "get it." Regardless of whether it's on the web or face to face, bolster bunches offer a special chance to share regular encounters. You can get and give bolster in the meantime. Individuals from help bunches frequently frame solid obligations of kinship. You can discover bolster bunches in your general vicinity through your oncologist's office, a nearby healing facility, or place of love. You can likewise look at these online gatherings: BreastCancer.org Forum: Stage IV and Metastatic Breast Cancer ONLY. CancerCare Metastatic Breast Cancer Patient Support Group. Shut Metastatic (Advanced) Breast Cancer Support Group (on Facebook). Inspire.com Advanced Breast Cancer Community. TNBC (triple-negative bosom disease) Metastasis/Recurrence Discussion Board. Wellbeing and home administrations: Many inquiries emerge when you're living with cutting edge bosom disease. Who will help when you can't drive yourself to treatment? Where would you be able to purchase therapeutic items? In what capacity will you locate the home care enable you to require? Your oncology office gets these inquiries constantly. They can most likely give a rundown of administrations and suppliers in your general vicinity. Here are a couple of all the more great assets to attempt: American Cancer Society Services gives data on an assortment of administrations and items, including: money related assets. male pattern baldness, mastectomy items, and other medicinal items. All Photos Licensed Under CC Source : www.pexels.com www.pixabay.com www.commons.wikimedia.org
Просмотров: 1067 Red Health
Saturday Morning, April 20, Keynote Speech for our 2018 Conference on Metastatic Breast Cancer. "Today's Research: Open Clinical Trials and Recent Findings" from Virgina F. Borges, MD, MMSc "Findings from the Bench: the Future of Metastatic Breast Cancer Care" from Suzanne A. W. Fuqua, PhD In the first of this two-part talk, Dr. Borges will speak about how metastatic breast cancer is treated today, the most recent significant research findings that may influence your care, and promising clinical trials underway. During part two, Dr. Fuqua will explore how her lab research may help us learn what drives some hormone receptor-positive breast cancers to return, what makes them become resistant to treatment, and what researchers hope they can do to make these cancers sensitive to hormone-targeting therapy again.
Просмотров: 555 Living Beyond Breast Cancer
Commenting on the findings from IMpassion130 and SOLAR-1 trials presented at ESMO 2018 Congress, Dr. Alessandra Gennari says that these two important study results will change the treatment of advanced breast cancer. In conclusion, Dr Gennari remarks that the IMpassion130 study shows that we can improve the prognosis of metastatic triple negative breast cancer with immunotherapy, while the SOLAR-1 points out to a new Pi3K inhibitor alpelisib in ER-positive, HER2-negative disease and which appears to be less toxic than previously developed Pi3K compounds. ESMO 2018 Congress abstracts: LBA1: IMpassion130: Results from a global, randomised, double-blind, phase 3 study of atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naive, locally advanced or metastatic triple-negative breast cancer (mTNBC); Peter Schmid LBA3: Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): results of the Phase 3 SOLAR-1 trial; Fabrice André Produced by the European Society for Medical Oncology http://www.esmo.org
Просмотров: 443 European Society for Medical Oncology
http://www.einstein.yu.edu - In this award-winning film that was featured on the NIH Director’s Blog, M.D./Ph.D. student Edison Leung says that he and his colleagues make movies of all genres—horror, action, thriller, and war—as they capture imaging inside living breast cancer tumors. Using a combination of live cell imaging in mice, 3D animation and analogies of espionage, Edison and postdoc Allison Harney demonstrate how cutting edge research can lead to counter attacks against breast cancer metastasis. Edison was one of three scientists who won a Celldance 2015 filmmaking award from the American Society for Cell Biology (ASCB) to create a video about cell research that is understandable to the general public. He and Allison work in the lab of John Condeelis, Ph.D. at Albert Einstein College of Medicine. [Creative Director/Writer: Sunita Reed; Editor: Charles Young, Einstein Communications Dept.] Read the NIH Director’s blog post: http://directorsblog.nih.gov/2016/02/04/cool-videos-spying-on-cancer-cell-invasion/ Read Edison’s blog post, Five Ways Filmmaking Helped an M.D./Ph.D. Student Become a Better Science Communicator: http://blogs.einstein.yu.edu/five-ways-filmmaking-helped-an-m-d-ph-d-student-become-a-better-science-communicator/
Просмотров: 5184 Albert Einstein College of Medicine
Dr Cardoso talks to ecancer at ESMO 2018 in Munich about the latest in breast cancer research reported at the conference. She highlights the results from SOLAR-1, IMpassion130, and PALOMA-3 as important, and reflects on the need for trial designs with overall survival as a co-endpoint from the outset. Dr Cardoso also discusses the impact of CDK inhibitors on breast cancer care, and how research in disease progression after CDK therapy is required. ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Просмотров: 3 ecancer
Hear personal stories from women living with advanced (metastatic) breast cancer in all stages of diagnosis, treatment and recovery. Listen as they talk about their strengths, struggles, and how their diagnosis changed their lives.
Просмотров: 27264 Living Beyond Breast Cancer
Significant advances have elevated breast cancer care to new levels of success and complexity. One such advance has been the availability of cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors in women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC). Please join expert faculty discussing highlights of a satellite symposium held June 4, 2016 at the annual oncology meeting that explores the current and expanding pool of information about these agents, as well as best practices for their current and potential use in MBC. Earn CME credit for this activity at the following location: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7209 © 2016 Imedex, LLC.
Просмотров: 110 ImedexCME
Stage 4 breast cancer treatment options Heal Breast Cancer Naturally: https://amzn.to/2JiWQGj Stage 4 breast cancer is also known as metastatic breast cancer. It is the most advanced stage of breast cancer, in which the cancer is spread beyond the breast area to other organs in the body, most often the bones, lungs, liver or brain. Treatment for stage 4 breast cancer doesn’t cure the disease. Patients with stage 4 breast cancer may live for years, but it’s usually life-threatening at some point Stage 4 breast cancer treatment options 1. Chemotherapy 2. Hormone therapy 3. Radiation therapy 4. Surgery 5. Targeted therapy These are 5 popular Stage 4 breast cancer treatment options which modern medicine can offer, However, Remember that prevention is better than cure. ------------------------------------------------------------------------------------------------------------ For more health tips visit ► https://www.healthveins.com All About Beauty ► https://www.healthveins.com/be Find Us On Amazon ► https://www.amazon.com/shop/healthveins Follow us on Facebook ► http://www/facebook.com/healthveins Join Facebook Group ► https://www.facebook.com/groups/225183354567275/ ------------------------------------------------------------------------------------------------------------ Disclaimer: The videos posted by Healthveins are for an educational or informational purpose only, and we are not liable for any harm or side effects if caused. You may use the remedies at your own risk. The Channel / Author does not provide medical advice. Consult with your doctor or other health care provider before using any of these tips or treatments. Copyright We reserve copyright for the music, voice, and animations used in the video. Reusing our video would violate copyright rules, And if found they could face legal copyright claims. Any images used are complying with the youtube terms: https://www.youtube.com/yt/copyright/fair-use.html
Просмотров: 35784 Healthveins
Fast forward to today, after 6 rounds of chemo (sorry I haven't had time to edit and upload my vlogs but I'll definitely go back in time later), I finally receive my CT scan results which determine whether or not I need more chemo, or if I can move on to hormone therapy... the results? POSITIVE!!! My 6th round was finally, MY LAST!!! In this video I show the anxiety a cancer patient gets waiting for results. It's tough to watch but it's real! Read my blog at http://www.nalie.ca/blog SUBSCRIBE: http://www.youtube.com/nalieagustin FOLLOW ME: http://www.instagram.com/nalieagustin LIKE ME: http://www.facebook.com/officialnalie TWEET ME: http://www.twitter.com/nalieagustin DOWNLOAD MY GUIDE: http://www.chemosecrets.ca
Просмотров: 243363 Nalie Agustin
Following an introduction by moderator Adam M. Brufsky, MD, PhD, panelists discuss available frontline therapies for patients with metastatic breast cancer. To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community
Просмотров: 291 OncLiveTV
Ibrance (palbociclib) is a promising new hormone based cancer treatment for advanced breast cancer. This new drug is intended to help patients who are post menopausal and whose metastatic cancer tests positive for an estrogen receptor (ER) as well as tests negative for the HER2 protein. In this cancer education video Dr. Stephen Lemon talks about how this targeted therapy works as well as mentions the types of side effects patients may experience. Visit http://www.canceris.net to find and share cancer information. #Ibrance is made by Pfizer. Dr. Stephen Lemon is a medical oncologist and is not affiliated with #Pfizer. #MetastaticCancer Dr Stephen Lemon is medical oncologist who now practices at Overlake Cancer Center Bellevue WA. He produces cancer information videos and web related cancer education projects. He invites you to follow his ongoing work at http://lightersideofcancer.com
Просмотров: 6195 Oncology Associates
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
Просмотров: 12 NUFeinbergMed
Approximately 155,000 Americans are currently living with advanced breast cancer which is the cause of approximately 40,000 deaths annually. Advanced metastatic breast cancer may spread to the bone in as many as 73% of cases. Hear first-hand from a patient living with metastatic breast cancer.
Просмотров: 5121 Amgen
Approximately 155,000 Americans are currently living with advanced breast cancer which is the cause of approximately 40,000 deaths annually. Advanced metastatic breast cancer may spread to the bone in as many as 73% of cases. Hear first-hand from a patient living with metastatic breast cancer.
Просмотров: 4138 Amgen
ABC Global Alliance Chair, Fatima Cardoso, explains what advanced and metastatic breast cancer is, how ABC patient needs are largely unmet, and how the ABC Global Alliance can help improve this. For more information, please visit www.abcglobalalliance.org
Просмотров: 249 ABC Global Alliance
Which of these videos did you find the most amazing? Let us know in the comments below. SUBSCRIBE to the YOUTUBE ONE channel for the most incredible videos just like this, thanks for watching!
Просмотров: 28 YouTube ONE
This video of "Cancer Metastasis in the Bones - All Symptoms" will deal extensively with the phenomenon of metastasis that appear in any of the bones of the body, which is one of the sites where the cells of many cancers are going to live in people with advanced cancer. We will see what symptoms the person who has metastasis in one or more of their bones can perceive, regardless of the origin of the same in the form of cancer of any organ of the body. We will learn why these symptoms occur, learning what happens inside the body Do not miss it! Subscríbase to this channel! http://www.youtube.com/user/danielgonzalezMD?sub_confirmation=1
Просмотров: 94738 Daniel González M.D.
Seven years ago, Suzanne Hebert was diagnosed with metastatic breast cancer that spread to her liver and bones. After four rounds of chemotherapy and decreasing response rates, she decided it was time for a change. That change came after advice from a friend, who also had advanced breast cancer, and was enrolled on a clinical trial at MD Anderson. The trial combined two drugs, everolimus, and a hormone therapy called arimidex. A different trial named BOLERO-2, or Breast Cancer Trials of Oral Everolimus, showed that combining everolimus with a different hormone therapy, exemestane, dramatically improved progression-free survival for women with advanced breast cancer. This week, the BOLERO-2 study was presented at the San Antonio Breast Cancer Symposium by Gabriel Hortobagyi, M.D., professor and chair of the Department of Breast Medical Oncology at MD Anderson. To learn more about the BOLERO-2 trial, visit http://bit.ly/rt8ObP.
Просмотров: 2319 MD Anderson Cancer Center
In her first video with Breastcancer.org, Jeanne, 33 years old, shares what she's learned since being diagnosed with metastatic breast cancer: "I'm not just surviving, I'm thriving."
Просмотров: 2350 Breastcancer.org
Dr. Peter Schmid reports on key results from ESMO 2018 Congress: LBA1_PR: IMpassion130: Results from a global, randomised, double-blind, phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in treatment-naive, locally advanced or metastatic triple-negative breast cancer. Produced by the European Society for Medical Oncology http://www.esmo.org
Просмотров: 2491 European Society for Medical Oncology
The women talk about how priorities shift after a metastatic breast cancer diagnosis. Some women share how work continues to bring meaning and purpose to their lives, while another speaks of how the diagnosis prompted her to spend more time with family.
Просмотров: 2107 Breast Cancer Network Australia
Source: https://www.spreaker.com/user/7078249/itunes-michael-pehl In this edition of The Onco’Zine Brief, recorded during the Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, June 1 - 5, 2018, Peter Hofland and Sonia Portillo talk with Michael Pehl, President and Chief Executive Officer of Immunomedics, a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC). At this year’s ASCO meeting, nearly 40,000 attendees gathered to discuss the growing body of data on advanced, difficult to treat diseases that do not have many treatment options. Hofland and Portillo speak with Pehl about some of the exciting developments that are taking place at this year’s meeting, including some of the data that his company presented about advancements in the development of targeted anti-cancer drugs such as antibody-drug conjugates. Traditional chemotherapy often fails to treat advanced or metastatic forms of cancer. This is because while chemotherapy disrupts tumors, it also harms other, healthy cells. In turn, this makes it difficult to deliver a potent anti-cancer drug, without causing too much harm to healthy cells. Antibody-drug conjugates on the other hand, are a form of targeted anti-cancer drugs that are able to target tumors cells, while sparing healthy cells. This means that more of an anti-cancer drugs can be delivered to the tumor, with less side effects. However, developing successful antibody-drug conjugates has remained a challenge for several decades. And to date only 4 different antibody-drug conjugates have been approved for the treatment of various forms of cancer. Hofland and Portillo ask Pehl how antibody-drug conjugate can be used for the treatment of advanced or metastatic triple negative breast cancer, a form of breast cancer that occurs in about 10% - 20% of all cases of breast cancer. In this type of cancer, the tumor cells lack the expression or amplification of targetable biomarkers, such as receptors for estrogen, progesterone, and human epidermal growth factor receptor 2, also known as HER2. Because in this type of cancer the cancer does not have the most common types of receptors known to fuel most cancer growth, common treatments like hormone therapy and drugs that target estrogen, progesterone, and HER2 are ineffective. Hence the name, triple negative. Using chemotherapy to treat triple negative breast cancer is still an effective option. In fact, triple negative breast cancer may respond even better to chemotherapy in the earlier stages than many other forms of cancer. But this type of cancer is extremely hard to treat, and – generally - has a poor prognosis. As many as 50% of patients diagnosed with early stage triple-negative breast cancer - that is stages 1 to 3 - experience disease recurrence, and 37% of patients die in the first 5 years after surgery. And while, as mentioned earlier, patients with metastatic or advanced triple-negative breast cancer may respond to chemotherapy, they do not always respond very well to traditional chemotherapy. These patients typically see a median progression free survival of only 3 to 4 months after failure of first-line of chemotherapy. Now, who are at risk for Triple negative breast cancer? As mention earlier, the disease occurs in about 10-20% of patients diagnosed breast cancers. The disease is also more likely to affect younger people, African Americans, Hispanics, and/or those with a BRCA1 gene mutation. In general, triple negative breast cancer can be more aggressive and difficult to treat. Also, the cancer is more likely to spread and recur. The stage of breast cancer and the grade of the tumor will influence the prognosis. For anti-cancer drug developers and oncologists treating this type of breast cancer, triple negative breast cancer is a major unmet medical need. To try meet this need, Immunomedics recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for a new antibody-body drug conjugate for the treatment of patients with advanced or metastatic triple negative breast cancer who previously received at least two prior therapies for metastatic disease. Hofland and Portillo speak with Dr. Pehl about some of the latest data his company presented about a first-in-class drug – and how precision medicines for cancer, including antibody-drug conjugates, can be used for the treatment of advanced or metastatic triple negative breast cancer.
Просмотров: 527 Onco'Zine - The International Oncology Network
In this video, Dr. David A. Margileth discusses the various approaches to dealing with bone-only metastatic breast cancer, including explanations of the advantages and disadvantages to each. Click Here & Get The 15 Breast Cancer Questions To Ask Your Doctor http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask/# Breast Cancer Answers is a social media show where viewers submit a question and get the answer from an expert. Submit your question now at, http://www.breastcanceranswers.com/ask. This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.
Просмотров: 28827 Breast Cancer Answers®
Patricia Quintana, 51 years of age, was diagnosed with invasive ductal carcinoma of the breast with bone and liver metastases. After 4 weeks into the Issels Treatment patient recovered her mobility without pain, her tumor marker decreased and overall condition markedly improved. End of January 2009, Patricia reports to be in very good condition. The Issels Treatment is a comprehensive immunotherapy program that integrates the most effective state-of-the-art technologies, such as advanced cancer vaccines, and other safe and scientifically validated therapies. For more information on the Issels Treatment, please visit http://www.issels.com or call 1.888.447.7357.
Просмотров: 15345 Issels Immunotherapy
SIX ADVANCED BREAST CANCERS - Complete Clinical Regressions Following Atavistic Chemotherapy: www.AtavisticChemotherapy.com In addition to their locally advanced breast cancer or local recurrence, most of these patients whose breast cancers are depicted in the film had metastases in different parts of the body. However, we show the images of breast cancer per se or surgical recurrence because they are more illustrative and it is easier to appreciate the response to treatment (using images of bone or liver metastases would be difficult to explain or see by a lay person). Please take a look and forward the link to this video to all those women or men with cancer. You may save a life!! If you are suffering of a different type of cancer, you need to watch this video: https://www.youtube.com/watch?v=JvdWsQQa598
Просмотров: 21708 Dr. Frank Arguello
Jasdeep came into CancerStories to tell a brave account of how she faced advanced stage IV breast cancer with metastases. Despite this she shows the importance of getting support, having a sense of humour and try out normal activities. Jas you are an inspiration to many facing this diagnosis! 1:35 - Introduction 2:57 - Chapter 1 8:05 - Chapter 2 11:29 - Chapter 3 16:33 - Chapter 4 19:00 - Chapter 5 22:26 - Chapter 6 27:20 - Ending credits Story by: Jasdeep Tara Diagnosis: Breast Cancer Interviewer: Alex J Mitchell Music: Emma O'Brien Resolution: 1080p Permissions: Email firstname.lastname@example.org Twitter: www.twitter.com/cancer_stories Facebook: www.facebook.com/cancerstoriesonline
Просмотров: 981 MyCancerStory
Living Beyond Breast Cancer, Metastatic Breast Cancer Network and Genentech created Faces of Metastatic Breast Cancer (MBC) to recognize the 155,000 people in the United States living with this incurable disease. Faces of MBC features the emotional journey of women living with MBC and provides a forum for them to share their amazing stories courage. Thank you to everyone who viewed this video on Metastatic Breast Cancer Awareness Day 2010 (Oct. 13) to help raise money and awareness. Faces of MBC will be up through October and beyond, so please continue to watch and share with others.
Просмотров: 48470 FacesofMBC
#XLIX = 49 Btw, AI is not "artificial intelligence", its "aromatase inhibitor". Aromatase is a enzyme that converts androgens to estrogen, that drives fuel to cancer cells. About Abemaciclib: Its used to treat certain types of breast cancer. Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Its a CDK4 and 6 inhibitor for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones. I DO NOT OWN THIS. ALL RIGHTS TO ELI LILLY.
Просмотров: 2804 C. B. MCMXCIX
Fatigue is a common side effect of metastatic breast cancer treatment. Four young women living with metastatic breast cancer discuss how fatigue impacts their lives and their strategies for managing it. Healthcare providers Don Dizon, MD, FACP, and Lori Ranallo, RN, MSN, APRN-BC, provide insight on why treatment causes fatigue and options for managing fatigue, including complementary therapies. Complete an evaluation for a chance to win a $25 gift card: https://www.surveymonkey.com/s/2014LBBC This video was supported by Cooperative Agreement Number DP11-1111 from The Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention
Просмотров: 3979 Living Beyond Breast Cancer
Prof Schmid speaks with ecancer at ESMO 2018 in Munich to discuss results from the IMpassion 130 trial of atezolizumab versus placebo in combinations with nab-paclitaxel to treat advanced and metastatic breast cancers. The experimental combination of PD1 immunotherapy produced improvements in PFS and OS among PD-L1 positive patients, though no benefit was seen in PD-L1 negative patients. Prof Schmid discusses the tolerability of the drug and the significance of immunotherapy entering breast cancer therapy options, and considers upcoming trials employing checkpoint immunotherapy. For more on this data, watch his presentation of the trial results at a conference session. ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
Просмотров: 28 ecancer
Terminal breast cancer means it is a stage 4 breast cancer and the individual has got a spread of the disease in the different parts of the body itself and patient may not survive for a very long time and to bring to the disease free status also is very difficult. Whereas advanced stage breast cancer means the breast cancer is a very advanced stage of breast cancer, one is a locally advanced breast cancer and metastatic advanced breast cancer is also present. But with therapy there is a good control of the disease. Therapy as in it could involve surgery, radiotherapy and chemotherapy. All these therapies, but you can bring the disease under control with all these treatments. But with terminally ill breast cancer patients, there is no treatment that is going to heal anymore and there is not in going on treating these patients also except palliative care, whether you give chemotherapy or radiotherapy, anything you give as a palliation. World's Largest Video Heath Platform is now in Hindi Subscribe to - https://www.youtube.com/channel/UCS1y5nTRddMYnozjN9iw0mA for HINDI videos
Просмотров: 108 Doctors' Circle - World's Largest Health Platform
For young mom, Pam Seeley, when breast cancer metastasized to her brain, minimally invasive laser surgery was presented as an option for treatments. She shares her story, along with Dr. Robert Wharen, neurosurgeon, who talks more about the laser ablation technique.
Просмотров: 6113 Mayo Clinic
Researchers at Rutgers Cancer Institute of New Jersey are leading a study testing the PD-1 inhibitor pembrolizumab with fulvestrant in patients with advanced/metastatic hormone receptor positive, HER2-negative breast cancer. Learn more at https://www.bigtencrc.org/clinical-research/current-trials/btcrc-bre16-042/
Просмотров: 294 Big Ten Cancer Research Consortium
Vera was with her family in Elk City when she fell and ended up in the hospital. Scans showed she had fractured her hip. They also showed spots on her bone. Vera was diagnosed with advanced breast cancer which had metastasized to the bone. Vera’s daughter did her research and found the PinnacleHealth Breast Care Center at the Ortenzio Cancer Center. She knew her mother wanted to stay close to home for treatment. What she didn’t know was that her mother didn’t want to have chemo, radiation or surgery. The breast oncologist at the Breast Care Center prescribed Ibrance, a pill that would help to treat Vera’s breast cancer. Vera is so thankful for the Breast Care Center. She says the physicians and staff are all just wonderful. She has no pain and the medication is working. Learn more about the treatment options offered by the PinnacleHealth Breast Care Center at https://www.UPMCPinnacle.com/phbcc
Просмотров: 82 UPMC Pinnacle
U.S. Congress Considering a National Proclamation to Recognize the Underrepresented Metastatic Breast Cancer Community Guests: · William J. Gradishar, MD FACP, Professor of Medicine; Director, Breast Medical Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine · Pamela Lipton, living with metastatic breast cancer Background: The public face of breast cancer has largely been focused on survivorship and early detection, with little attention given to those who develop metastatic breast cancer (MBC), the most advanced stage of the disease that requires life-long treatment. While October, Breast Cancer Awareness Month symbolizes a sense of community for women with early breast cancer, women living with MBC often feel isolated from the broader community during this time. According to the recent BRIDGE Survey (Bridging Gaps, Expanding Outreach Metastatic Breast Cancer Patient Survey) of 950 women living with MBC, nearly seven in 10 women (67 percent) desire increased public awareness of MBC. The truth is that thirty percent of women initially diagnosed with earlier stages of breast cancer will eventually develop advanced or metastatic disease. There are currently 155,000 women in the U.S. living with MBC who want their voices heard. Whats New? Congressional Proclamation of National MBC Awareness Day Through the efforts of breast cancer advocates nationwide and the Metastatic Breast Cancer Network, United States Congress is considering a national proclamation of October 13th as National Metastatic Breast Cancer Awareness Day. Many cities and states nationwide already observe October 13th as MBC Awareness Day. October 13th recognizes the thousands of women living with MBC, who beyond seeking a cure, desire public support that pays tribute to their unique experiences living with the disease. BRIDGE Survey A recent assessment of 950 women living with MBC in nine countries, including the United States, revealed that despite the negative impact of their disease, a majority of women with MBC still enjoy life and 50 percent consider themselves to be a cancer survivor.
Просмотров: 2657 GoodNewsBroadcast
Hear about the latest treatment advances for each subtype and learn about research in the pipeline that could lead to future treatment options.
Просмотров: 619 Living Beyond Breast Cancer